Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Timolol Maleate for IOP Elevation After Nd:YAG Laser Capsulotomy
NCT07729189Completed
- Sponsor
- CMH Multan Institute of Medical Sciences
- Start
- Mar 2025
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Randomised, single-blind trial of timolol in ocular hypertension (2 arms), sponsored by CMH Multan Institute of Medical Sciences. Primary endpoint: Mean Intraocular Pressure at 1 hour. Started Mar 2025; status: completed.
02
Drugs
timolol
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on NCT07729189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07729189.